ArticleJournal of causal inference2026
HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-response Curve.
Article in Journal of causal inference, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- HIGHLY ADAPTIVE LASSO: MACHINE LEARNING THAT PROVIDES VALID NONPARAMETRIC INFERENCE IN REALISTIC MODELS.medRxiv : the preprint server for health sciences · 2024Article
- One-Step Estimation of Differentiable Hilbert-Valued Parameters.Annals of statistics · 2024Article
- Estimating mean potential outcome under adaptive treatment length strategies in continuous time.Biometrics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Estimating and obtaining reliable inference for the marginally adjusted causal dose-response curve for continuous treatments without relying on parametric assumptions is a well-known statistical challenge. Parametric models risk introducing significant bias through model misspecification, compromising the accurate representation of the underlying data and dose-response relationship. On the other hand, nonparametric models face difficulties as the dose-response curve is not pathwise differentiable, preventing consistent estimation at standard rates and making the construction of confidence intervals challenging. The Highly Adaptive Lasso (HAL) maximum likelihood estimator offers a promising approach to this issue. In this paper, we introduce a HAL-based plug-in estimator for the causal dose-response curve, bridge between recent theoretical developments and empirical applications, and assess its empirical performance against other estimators. This work emphasizes the translation of existing HAL asymptotic theory to the causal dose-response setting and demonstrates its practical implications through comprehensive simulations, thereby filling an essential gap between theory and practice. Our comprehensive simulations demonstrate that the HAL-based estimator approaches pointwise asymptotic normality under the assumed smoothness conditions and yields confidence intervals that are consistently closer to nominal coverage than those of competing methods. While undercoverage can persist in more complex settings at moderate sample sizes, the HAL estimator consistently outperforms existing approaches for estimating the causal dose-response curve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.